Vanderbilt Vaccine Center Archives
Antibodies may be ‘silver bullet’ for Ebola viruses
Jan. 21, 2016—There may be a “silver bullet” for Ebola, a family of hemorrhagic viruses, one of which has killed more than 11,000 people in West Africa in the past two years.
VUCast: How Ebola survivors are teaming with Vanderbilt to fight the deadly virus
Oct. 16, 2015—In the latest VUCast: Hear from Ebola survivors helping a Vanderbilt researcher fight the deadly virus; see the high-tech way an art exhibit is bringing VU students face to face with people across the world; and find out which country music star shot his latest video with Mr. Commodore! Watch now.
Survivors of Ebola outbreak take part in VUMC vaccine study
Sep. 24, 2015—Two survivors of a 2014 Ebola outbreak in Nigeria visited Vanderbilt University Medical Center last week to share their experiences and participate in a study aimed at finding ways to treat the often-fatal infection.
Ebola symposium to feature Nigerian physicians
Sep. 10, 2015—Three Nigerian physicians who survived Ebola virus disease in July 2014 after coming in direct contact with an Ebola-infected patient will speak at Vanderbilt University Medical Center next Wednesday, Sept. 16.
How to trick a wily virus
Jul. 24, 2015—Vanderbilt investigators have discovered how human antibodies induced during testing of an experimental “bird flu” vaccine kill the virus.
Study could lead to vaccine for mosquito-borne dengue virus
Jul. 9, 2015—Researchers at Vanderbilt University and the National University of Singapore have determined the structure of a human monoclonal antibody which, in an animal model, strongly neutralizes a type of the potentially lethal dengue virus.
Vanderbilt researchers develop potential treatment to fight mosquito-borne chikungunya virus
Jul. 8, 2015—In late 2013 the Caribbean had its first case of the mosquito-borne chikungunya virus. Today there have been almost 1.2 million cases in 44 countries or territories, including 177 cases in 31 U.S. States.
‘Redesigned’ antibodies may control HIV: study
May. 21, 2015—With the help of a computer program called “Rosetta,” researchers at Vanderbilt University have “redesigned” an antibody that has increased potency and can neutralize more strains of the AIDS-causing human immunodeficiency virus (HIV) than can any known natural antibody.
VU lands $9 million NIH grant to design better flu vaccines
May. 15, 2015—Vanderbilt University researchers have received a five-year, $9 million grant from the National Institutes of Health (NIH) to design more effective flu vaccines and novel antibody therapies.
VU joins national effort to speed Ebola therapy testing
Apr. 8, 2015—Vanderbilt University researchers have joined a multi-center effort led by Pennsylvania-based Inovio Pharmaceuticals Inc. to accelerate development of potential antibody therapies against the often-lethal Ebola virus.
Vanderbilt researchers isolate Ebola-fighting human antibodies for possible treatment
Oct. 28, 2014—Vanderbilt University researchers have isolated Ebola-fighting human antibodies – the first of their kind – that could lead to a new treatment for the deadly virus.
Alexander’s visit highlights efforts to confront Ebola
Sep. 24, 2014—Don’t panic over Ebola. But don’t ignore it, either. That was the take-home message for U.S. citizens from a “mini-hearing” held by U.S. Sen. Lamar Alexander, R-Tenn., at Vanderbilt University Medical Center on Wednesday with researchers and health officials from Vanderbilt and the State of Tennessee.
